Development of novel vaccines: Goethe University founding team receives federal funding
Two young chemists at Goethe University want to develop highly effective vaccines using the carrier protein dodecin. To develop their
Two young chemists at Goethe University want to develop highly effective vaccines using the carrier protein dodecin. To develop their
About ten percent of Parkinson’s cases can be ascribed to mutations in the LRRK2 gene. Five research teams from the
When the body can no longer compensate the gradual failure of the liver caused by liver cirrhosis, there is a
Since the beginning of the pandemic, research groups have been working on methods to detect SARS-CoV-2 viruses in wastewater to
In cooperation with East Yangon University in Myanmar and the Max-Planck Institute for Chemical Ecology in Jena, researchers at Goethe
CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind
The Institute of Medical Virology at Goethe-University, Frankfurt am Main, Germany, and the University of Kent’s School of Biosciences (UK)
Acute lymphoblastic leukaemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can
Speaking requires both sides of the brain. Each hemisphere takes over a part of the complex task of forming sounds,
A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human
Goethe University and University Hospital Frankfurt donation barometer increases to 1.35 million euros – smallest individual donation of 2 cents
The governmental decision on when to loosen social distancing measures should not only depend on the latest number of cases.
The target is € 5 million and € 1 million have already been firmly pledged: The donation appeal launched just
Researchers at the German Red Cross Blood Donor Service in Frankfurt headed by Professor Erhard Seifried, and the Institute for
Goethe University and University Hospital Frankfurt ask for funding for research, equipment and patient care At least five million euros
Attack or peacekeeping? Immune cells answer this question countless times a day. If they regularly missed the mark, it would
PROXIDRUGS, the regional network led by Goethe University, aims at developing active molecules for selective intervention, opening new therapeutic avenues.
Whether a sick cell dies, divides, or travels through the body is regulated by a sophisticated interplay of signal molecules
When cells are stressed, they initiate a complex and precisely regulated response to prevent permanent damage. One of the immediate
The non-invasive measurement of blood flow to the heart using magnetic resonance imaging (MRI) is on par with cardiac catheterization.
Goethe University and TU Munich have jointly obtained a new Collaborative Research Centre (Sonderforschungsbereich – SFB), which will receive approximately
Professor Ivan Dikic, Director of the Institute of Biochemistry II, has been elected to the venerable American Academy of Arts
Albumin in high doses improves cardiac function and reduces inflammation Decompensated cirrhosis is a chronic disease linked to numerous complications
Professor Ferdinand Gerlach, Director of the Institute of General Practice at Goethe University, has received the Alfons and Gertrude Kassel
A third of all patients in general practice suffer from multiple diseases. These patients are usually treated by various medical
Every year, a list is published of the top one percent of researchers worldwide, based on the frequency with which
Whether defective cells in the body will live or die is determined by a sophisticated control system. Death receptors play
Patients with rare diseases often go through a long history of suffering before finally receiving an accurate diagnosis. One reason
© 2023 Goethe-Universität Frankfurt am Main | Impressum | Datenschutzerklärung | Cookies verwalten
You cannot copy content of this page